A New AI Drug Discovery Startup Launched with $1 Billion in Capital
3 min readApr 23, 2024
As first reported by Endpoints News, Xaira Therapeutics has emerged as one of the most significantly funded new entrants in the biotech sector, supported by a consortium of venture capitalists and eminent scientists.
The startup has announced its mission to transform drug research and development (R&D) through the integration of artificial…
